ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

European Commission Approves Subcutaneous Rituximab

March 28, 2014

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

Advanced Screening Provides More Accurate Diagnosis

February 23, 2007

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

First Report On Carcinogens Now Avaiable

October 3, 1980